Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017
Cost: Free
View Offer chevron_rightDetails
Major Depressive Disorder (MDD): Updates from the American Psychiatric Association Annual Meeting (APA) 2017 includes major findings about major depressive disorder from APA 2017, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice.
After reviewing Major Depressive Disorder (MDD), you will be able to:
• Recall the most impactful findings about Major Depressive Disorder (MDD) from the APA 2017 Annual meeting relating to MDD pathophysiology, progression, & prognosis.
• Describe the most impactful findings about MDD from the APA 2017 Annual meeting relating to using the similarities & differences between MDD & bereavement to inform good clinical care.
• Summarize the most impactful findings about MDD from the APA 2017 Annual meeting relating to old, new, emerging, and potential new targets for treating of MDD and apply them to patient cases.
Target Audience:
Healthcare professionals specializing in family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with MDD or related psychiatric diseases.